HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mario Campone Selected Research

Glioma (Gliomas)

1/2022Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial.
1/2020Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study.
4/2016MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.
10/2012Folate supplementation limits the tumourigenesis in rodent models of gliomagenesis.
6/2012Comparison of immunohistochemistry, DNA sequencing and allele-specific PCR for the detection of IDH1 mutations in gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mario Campone Research Topics

Disease

174Breast Neoplasms (Breast Cancer)
05/2024 - 03/2002
96Neoplasms (Cancer)
10/2023 - 07/2003
18Triple Negative Breast Neoplasms
05/2022 - 11/2013
15Neoplasm Metastasis (Metastasis)
12/2023 - 08/2009
14Neutropenia
01/2023 - 12/2006
10Diarrhea
01/2021 - 11/2011
9Glioblastoma (Glioblastoma Multiforme)
10/2023 - 03/2009
9Nausea
01/2021 - 12/2006
8Fatigue
01/2022 - 11/2007
8Disease Progression
01/2022 - 11/2007
8Vomiting
01/2021 - 12/2006
7Carcinoma (Carcinomatosis)
12/2020 - 10/2015
6Brain Neoplasms (Brain Tumor)
01/2020 - 03/2009
6Carcinogenesis
11/2013 - 07/2003
5Glioma (Gliomas)
01/2022 - 06/2012
5Hyperglycemia
01/2019 - 11/2011
4Pneumonia (Pneumonitis)
01/2023 - 02/2012
4Leukopenia
01/2023 - 12/2014
4Exanthema (Rash)
10/2021 - 01/2017
4Prostatic Neoplasms (Prostate Cancer)
10/2020 - 03/2010
4Stomatitis
11/2017 - 12/2006
3Cardiotoxicity
03/2024 - 11/2004
3Infections
09/2023 - 12/2016
3Pain (Aches)
01/2021 - 06/2018
3Endometrial Neoplasms (Endometrial Cancer)
10/2020 - 01/2018
3Adenocarcinoma
05/2020 - 01/2006
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 03/2008
3Febrile Neutropenia
01/2018 - 12/2006
3Asthenia
11/2017 - 11/2011

Drug/Important Bio-Agent (IBA)

49Hormones (Hormone)IBA
01/2024 - 09/2005
33Trastuzumab (Herceptin)FDA Link
03/2024 - 07/2003
28ErbB Receptors (EGF Receptor)IBA
11/2023 - 12/2006
20EverolimusFDA Link
01/2024 - 06/2009
20Biomarkers (Surrogate Marker)IBA
01/2024 - 03/2006
18Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2006
18Docetaxel (Taxotere)FDA Link
11/2019 - 09/2005
16Estrogen ReceptorsIBA
11/2023 - 04/2006
16human ERBB2 proteinIBA
06/2023 - 12/2009
15AnthracyclinesIBA
03/2024 - 12/2006
15Aromatase InhibitorsIBA
11/2022 - 02/2012
14exemestane (Aromasin)FDA Link
01/2024 - 02/2012
12TOR Serine-Threonine KinasesIBA
01/2024 - 12/2010
12Progesterone Receptors (Progesterone Receptor)IBA
10/2020 - 04/2006
11Letrozole (Femara)FDA LinkGeneric
11/2023 - 06/2009
11Fulvestrant (Faslodex)FDA Link
01/2022 - 01/2017
10DNA (Deoxyribonucleic Acid)IBA
10/2022 - 09/2005
10ribociclibIBA
10/2022 - 11/2016
10Capecitabine (Xeloda)FDA Link
12/2019 - 12/2006
9Phenobarbital (Luminal)FDA Link
12/2021 - 11/2014
9Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2019 - 03/2006
9Epirubicin (Ellence)FDA LinkGeneric
11/2019 - 12/2004
9taxaneIBA
11/2019 - 12/2006
8Epidermal Growth Factor (EGF)IBA
10/2021 - 07/2007
8Paclitaxel (Taxol)FDA LinkGeneric
10/2020 - 03/2002
7abemaciclibIBA
10/2023 - 11/2017
7Bevacizumab (Avastin)FDA Link
10/2023 - 04/2012
7Carboplatin (JM8)FDA LinkGeneric
01/2022 - 07/2007
6pertuzumabIBA
03/2023 - 05/2013
6NVP-BKM120IBA
01/2020 - 01/2017
6Temozolomide (Temodar)FDA LinkGeneric
01/2020 - 03/2009
6Fluorouracil (Carac)FDA LinkGeneric
11/2019 - 03/2006
6ixabepilone (BMS 247550)FDA Link
11/2018 - 11/2007
5Lomustine (CCNU)FDA Link
10/2023 - 09/2013
5Tyrosine Kinase InhibitorsIBA
05/2023 - 12/2006
5Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2022 - 08/2014
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2021 - 12/2006
5Alanine Transaminase (SGPT)IBA
10/2021 - 01/2017
5Taxoids (Taxanes)IBA
09/2021 - 07/2003
5Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2020 - 01/2017
5Lapatinib (GW572016)FDA Link
11/2017 - 12/2006
4Cyclin-Dependent Kinase 4IBA
05/2024 - 11/2017
4AntibodiesIBA
05/2023 - 05/2020
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2021 - 01/2017
4AlpelisibIBA
02/2021 - 01/2019
4Vinorelbine (Navelbine)FDA LinkGeneric
12/2019 - 04/2009
4Ado-Trastuzumab EmtansineIBA
01/2019 - 04/2015
4vinflunineIBA
09/2016 - 10/2005
3Circulating Tumor DNAIBA
10/2023 - 10/2016
3GemcitabineFDA Link
01/2022 - 10/2006
3Monoclonal AntibodiesIBA
01/2022 - 01/2006
3PlatinumIBA
10/2020 - 09/2007
3AntigensIBA
05/2020 - 01/2011
3CytokinesIBA
01/2020 - 09/2009
3Androgen Receptors (Androgen Receptor)IBA
12/2019 - 01/2015
3eribulinFDA Link
12/2019 - 09/2010
3Phosphatidylinositols (Phosphatidylinositol)IBA
07/2019 - 09/2016
3Cyclin-Dependent Kinases (cdk Proteins)IBA
02/2019 - 11/2016
3ParaffinIBA
01/2019 - 11/2014
3Formaldehyde (Formol)FDA Link
01/2019 - 11/2014
3palbociclibIBA
10/2018 - 04/2018
3Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
10/2017 - 07/2013

Therapy/Procedure

68Therapeutics
05/2024 - 10/2003
53Drug Therapy (Chemotherapy)
03/2024 - 11/2004
14Neoadjuvant Therapy
03/2024 - 12/2006
10Radiotherapy
09/2023 - 12/2009
8Adjuvant Chemotherapy
01/2019 - 12/2006
6Aftercare (After-Treatment)
03/2021 - 12/2006
5Immunotherapy
09/2023 - 01/2011
3Precision Medicine
01/2022 - 01/2020
3Mastectomy (Mammectomy)
01/2020 - 07/2007